Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Ann Arbor, MI MSA — October 2026
Ann Arbor's clinical and regulatory pay diverge from national gains.
Ann Arbor Biostatistician pay climbed to $156,868, nearly 19% above the national median, while local CRA pay fell to $52,291 even as the national figure rose to $90,065.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Metro unemployment rate: 3.8% — vs 5.0% Michigan, 4.2% U.S. (Sept.)
- Biostatistician advertised pay: $156,868 — vs $131,958 national median, up significantly
- CRA advertised pay: $52,291 — down significantly vs $90,065 national, up significantly
- Michigan bioindustry employment: 47,815 jobs — up 42% since 2006, hiring now moderating
Key takeaways
Biostatistics pay is pulling away from the national market.
Metro Biostatistician pay at $156,868 now runs nearly 19% above the national median of $131,958, up significantly month over month. Demand for data-heavy, compliance-adjacent expertise appears to be concentrating locally, likely tied to clinical trial data management work anchored around University of Michigan-affiliated research.
CRA pay is falling locally while rising everywhere else.
Ann Arbor's Clinical Research Associate advertised pay dropped to $52,291, down significantly, even as the national median climbed to $90,065 on a nationally documented CRA talent bottleneck. That spread may signal local employers relying more heavily on CRO partnerships for clinical operations and competing less directly for scarce in-house CRA talent.
Regulatory affairs pay softness may understate real competition.
Metro Regulatory Affairs Specialist pay fell to $92,715, tracking a national decline but falling further locally. National research flags regulatory affairs as one of the hardest-to-fill life sciences functions in 2026, so a local pay pullback is harder to reconcile with that national scarcity and worth checking against actual time-to-fill data.
Validation Engineer gains track a manufacturing talent squeeze.
Advertised pay for Validation Engineer roles rose to $110,300, a significant increase that outpaces the flat national figure of $106,478. Rising local biomanufacturing and CDMO investment nationally is consistent with employers paying up for scarce compliance and manufacturing engineering expertise in Michigan's bioindustry base.
Median advertised pay by role — Ann Arbor, MI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $88,937 | $117,568 | $150,000 | Stable | $130,339 |
| Clinical Research Associate | $49,543 | $52,291 | $63,800 | Moderate decline | $90,065 |
| Lab Technician | $37,004 | $40,702 | $41,770 | Significant increase | $47,840 |
| Regulatory Affairs Specialist * | $68,604 | $92,715 | $110,788 | Significant decline | $103,780 |
| Clinical Data Manager * | $96,750 | $128,800 | $151,550 | Stable | $123,653 |
| Biostatistician | $126,096 | $156,868 | $156,868 | Significant increase | $131,958 |
| Validation Engineer * | $82,514 | $110,300 | $120,327 | Significant increase | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Ann Arbor's 3.8% unemployment rate holds well below the state's 5.0% and signals a labor pool constrained further by the University of Michigan, Eastern Michigan University, and the region's academic research base competing for the same scientific and technical talent that life sciences employers need. Statewide labor force contraction of 3.2% year-over-year compounds local scarcity, even as Michigan's bioindustry sector, now at 47,815 jobs, has shifted toward efficiency-driven hiring that leaves less room to absorb turnover in regulatory, quality, and clinical roles.
What it means
Local wage movements diverge sharply by function — Biostatistician pay up to $156,868 and Validation Engineer pay up to $110,300 point to employers paying a premium for roles tied to data integrity and manufacturing compliance, while declines in Clinical Research Associate ($52,291, down significantly) and Regulatory Affairs Specialist ($92,715, down significantly) advertised pay locally suggest softening demand or a shift toward outsourcing these functions to CROs as internal headcount growth slows. National CRA pay moved in the opposite direction, up significantly to $90,065, widening the metro-to-national gap and raising retention risk for any Ann Arbor employer still competing for experienced clinical operations talent. Organizations should evaluate whether falling local CRA and regulatory affairs advertised pay reflects a lasting market correction or a lag that will force a catch-up adjustment once CRO capacity tightens.
Looking ahead
Emerging pressure point: Navitas Systems' phased layoffs running through October 31 across three Ann Arbor locations may release technical and manufacturing-adjacent talent into the local pool. Watch whether any of these workers carry transferable skills into biomanufacturing or validation engineering roles.
Worth watching: Local CRA and regulatory affairs advertised pay is falling against a national pattern of significant increases in both roles. A continued divergence would strengthen the case for shifting more clinical and regulatory work to external CRO partners as in-house hiring for scarce talent becomes harder to sustain.
Expected: Washtenaw County's unemployment rate is forecast to edge down to 4.3% by year-end, tightening further against an already-low 3.8% metro rate. Expect longer time-to-fill and more counteroffer activity for credentialed scientific and quality roles through year-end.
Potential inflection point: Halting of the $645M MI BioTalent Connect grant removes a planned pipeline-building mechanism for manufacturing, quality, and clinical talent. Life sciences employers may need to lean more heavily on internal training and university partnerships to fill the gap this created.
Sources
- Michigan Department of Technology, Management & Budget — Ann Arbor unemployment rate at 3.8% through August 2026
- Michigan Department of Technology, Management & Budget — Michigan labor force declined 3.2% year-over-year
- Michigan bioscience industry research — Michigan bioindustry employment reached 47,815 jobs in 2024
- Biopharma industry hiring survey — Regulatory affairs flagged as hardest-to-fill pharma role in 2026
- Upjohn Institute Michigan Layoff Tracker — Navitas Systems layoffs across three Ann Arbor locations through Oct. 31
- Michigan Strategic Fund — MI BioTalent Connect $645M grant halted before 2026 launch
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.